Search Results - "Poo, Jorge–Luis"
-
1
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
Published in Annals of hepatology (2011)“…Hyperammonemia and associated cerebral edema cause neurological abnormalities in liver disease patients. Although only 15% of ammonia production originates in…”
Get full text
Journal Article -
2
Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: A randomized, open-label, single-dose, two-period crossover comparison in healthy mexican adult volunteers
Published in Clinical therapeutics (01-09-2008)“…Abstract Background: Ketorolac tromethamine (ie, ketorolac) is an NSAID that appears to have several mechanisms of action, including inhibition of…”
Get full text
Journal Article -
3
Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C
Published in Gastroenterology (New York, N.Y. 1943) (01-06-2011)“…Background & Aims Several studies have reported that low doses of interferon can delay the development of hepatocellular carcinoma (HCC) and progression of…”
Get full text
Journal Article -
4
Hepatic hematoma and hepatic rupture in pregnancy
Published in Annals of hepatology (01-07-2006)“…Hepatic perforation is an unusual complication of woman pregnancy associated with a poor outcome. A comprehensive review of epidemiology, clinical spectrum,…”
Get full text
Journal Article -
5
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
Published in Hepatology international (01-09-2020)“…Background and aims Pirfenidone (PFD), an oral antifibrotic drug, has been authorized by the EMA and FDA for treatment of idiopathic pulmonary fibrosis. Few…”
Get full text
Journal Article -
6
Bioavailability of Two Single-Dose Oral Formulations of Omeprazole 20 mg: An Open-Label, Randomized Sequence, Two-Period Crossover Comparison in Healthy Mexican Adult Volunteers
Published in Clinical therapeutics (01-04-2008)“…Abstract Background: Omeprazole is a proton-pump inhibitor that acts to reduce acid secretion in the stomach and is used for treating various acid-related…”
Get full text
Journal Article -
7
Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023
Published in Annals of hepatology (01-02-2024)“…Advanced liver fibrosis (ALF) is a predictor of adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or…”
Get full text
Journal Article -
8
Hepatitis C virus infection and non-Hodgkin’s lymphoma: a review and case report of nine patients
Published in Annals of hepatology (01-10-2006)“…The role of hepatitis C virus (HCV) is well established in the development of chronic hepatitis, cirrhosis and hepatic carcinoma, as well as in mixed type II…”
Get full text
Journal Article -
9
Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study
Published in Annals of hepatology (01-10-2006)“…Despite steady progress in therapeutics of liver disease, portal systemic encephalopathy remains to be a great challenge for clinicians because of the…”
Get full text
Journal Article -
10
Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers
Published in Clinical therapeutics (01-08-2009)“…Abstract Background: Levofloxacin is a synthetic fluoroquinolone with a broad spectrum of antibacterial activity. It is indicated for the treatment of…”
Get full text
Journal Article -
11
Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: frequency and clinical manifestations
Published in Annals of hepatology (01-07-2005)“…To evaluate the frequency of hepatobiliary diseases and the clinical manifestations in patients with HIV treated with non highly active anti-retroviral…”
Get full text
Journal Article -
12
Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention
Published in The Journal of pharmacology and experimental therapeutics (01-04-1999)“…kappa-Opioid receptor agonists (niravoline) or nonpeptide antidiuretic hormone (ADH) V2 receptor antagonists (OPC-31260) possess aquaretic activity in…”
Get more information
Journal Article -
13
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
Published in Gastroenterology (New York, N.Y. 1943) (01-05-1999)“…Background & Aims: The critical role of cyclooxygenase (COX) products in maintenance of renal function in cirrhosis with ascites discourages the use of…”
Get full text
Journal Article -
14
Consenso latinoamericano de hepatitis C
Published in Medwave (01-07-2007)Get full text
Journal Article -
15
Treatment of patients with recurrence or who do not respond to the first treatment against hepatitis C
Published in Revista de gastroenterología de México (01-10-2002)“…The current criteria to confirm the absence of therapeutic response to HCV is based on the viral findings. Lack of response is defined as the failure to…”
Get full text
Journal Article -
16
Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study
Published in Journal of gastroenterology and hepatology (01-12-2004)“…Despite steady progress in antiviral treatment for patients with chronic hepatitis C virus(HCV), many patients still have detectable serum HCV RNA levels by…”
Get full text
Conference Proceeding Journal Article -
17
Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects
Published in Gastroenterology (New York, N.Y. 1943) (1999)“…Background & Aims: Because controversial roles have been attributed to activation of the hepatic paracrine endothelin (ET) system in cirrhosis, this study…”
Get full text
Journal Article -
18
Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study
Published in Journal of gastroenterology and hepatology (01-12-2004)“…Despite steady progress in antiviral treatment for patients with chronic hepatitis C virus (HCV), many patients still have detectable serum HCV RNA levels by…”
Get full text
Journal Article -
19
Hepatitis C virus infection and non-Hodgkin's lymphoma: a review and case report of nine patient
Published in Annals of hepatology (01-10-2006)“…The role of hepatitis C virus (HCV) is well established in the development of chronic hepatitis, cirrhosis and hepatic carcinoma, as well as in mixed type II…”
Get more information
Journal Article -
20
Influence of a patient education course on hospital and outpatient interventions in patients with liver cirrhosis
Published in Journal of hepatology (01-04-2002)Get full text
Journal Article